Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 147Melanoma 122Breast Neoplasms 98Squamous Cell Carcinoma of Head and Neck 96Triple Negative Breast Neoplasms 85Lung Neoplasms 64Neoplasm Metastasis 53Carcinoma, Renal Cell 49Neoplasms 46Head and Neck Neoplasms 46Colorectal Neoplasms 41Ovarian Neoplasms 38Carcinoma, Transitional Cell 37Carcinoma, Hepatocellular 36Pancreatic Neoplasms 35Urinary Bladder Neoplasms 34Recurrence 33Stomach Neoplasms 32Glioblastoma 30Brain Neoplasms 28Sarcoma 26Endometrial Neoplasms 25Prostatic Neoplasms 23Hodgkin Disease 22Uterine Cervical Neoplasms 19Fallopian Tube Neoplasms 19Carcinoma, Squamous Cell 19Esophageal Squamous Cell Carcinoma 17Adenocarcinoma 17Multiple Myeloma 16

Interventions

pembrolizumab 2perflutren 1Vinorelbine 1Thoracoscopy 1Surveys and Questionnaires 1Sulfur Hexafluoride 1Radiotherapy 1Prednisone 1Pemetrexed 1Paclitaxel 1Nivolumab 1Immune Checkpoint Inhibitors 1Hypnosis 1Health Records, Personal 1Gemcitabine 1Drug Therapy 1Dexamethasone 1Conscious Sedation 1Clinical Protocols 1Carboplatin 1Bronchoscopy 1Bronchoalveolar Lavage 1Blood Pressure 1Bevacizumab 1Behavior Therapy 1Adrenal Cortex Hormones 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Lung Diseases, Interstitial × pembrolizumab × Clear all
NCT07420439 2026-04-27

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

Intergroupe Francophone de Cancerologie Thoracique

Phase 2 Not yet recruiting
108 enrolled

Lung Diseases, Interstitial

NCT04807114 2024-07-01

A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC

Universitaire Ziekenhuizen KU Leuven

Recruiting
70 enrolled

Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡